阿魏酸钠治疗肺源性心脏病疗效观察

目的观察阿魏酸钠治疗肺源性心脏病（肺心病）急性发作患者的临床疗效。方法 42例慢性肺心病急性发作患者随机分为治疗组24例和对照组18例。对照组给予常规治疗,治疗组在对照组基础上加用阿魏酸钠注射液治疗。结果治疗组总有效率为91.7%高于对照组66.7%,差异有统计学意义（P〈0.05）;2组治疗后血气分析有明显改善,差异均有统计学意义（P〈0.05和P〈0.01）,其中治疗组缺氧及二氧化碳潴留的改善优于对照组,差异有统计学意义（P〈0.05）。结论阿魏酸钠结合常规疗法治疗肺心病有良好疗效。

Efficacy observation of SF treatment of pulmonary heart disease

Objective To observe the clinical efficacy of SF treatment of pulmonary heart disease.Methods 42 cases of patients with acute exacerbation of chronic pulmonary heart disease were randomly divided into treatment group of 24 cases and control group of 18 cases.The control group received conventional therapy,the treatment group was based on the control group used of sodium ferulate injection.Results The total effective rate of control group was 91.7% higher than 66.7% of control group,the difference was statistically significant （P0.05）; The indicators of blood gas analysis of the two groups after treatment significantly improved,the differences were statistically significant （P0.05 andP0.01 ）,oxygen and carbon dioxide of treatment group improved retention were better than the control group,the difference was statistically significant （P0.05）.Conclusion SF pulmonary heart disease combined with conventional therapy have a good effect.